Predicting Rupture of AAA by Anatomic and Hemodynamic Markers
NCT ID: NCT02463760
Last Updated: 2022-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2 participants
OBSERVATIONAL
2015-08-31
2022-02-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of Novel Imaging Markers Predicting the Progression of Abdominal Aortic Aneurysm Using 3D Computed Tomography
NCT04333641
Evaluation of Predictors of Aortic Aneurysm Growth and Rupture
NCT02022436
Non Invasive Imaging of Abdominal Aorta Aneurysm Hemodynamics and Wall Structure
NCT01104688
Development of Ultra-Low Dose CT Based Screening for Aortic Aneurysms
NCT03479164
Magnetic Resonance Imaging of Aortic Aneurysm Instability
NCT00794092
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medical imaging
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Or patients with known AAA with growth rate of 0-0.2 cm/year
* Or patients with known AAA with growth rate of greater than 0.5 cm/year.
Exclusion Criteria
* Penile implant
* Hip replacement
* History of shrapnel or shot gun injury
* Body mass index ≥ 30
* Cardiac pacemakers
* Severe claustrophobia
* Large tattoos on the torso
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Rosenberg, MD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
150023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.